FibroGen's GAAP loss for 2021 was $290.023 million, up 53.2% from $189.291 million in the prior year. Revenue increased 33.5% to $235.309 million from $176.319 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept